Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia

Por um escritor misterioso

Last updated 19 março 2025

Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia

October 1^st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.

Buy Rexulti Online - Brand Otsuka from Canada for Schizophrenia

ex9902006.jpg

PDF) Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole

Rexulti (Brexpiprazole) - PSYCH-MENTAL HEALTH HUB

Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. - Abstract - Europe PMC

Rexulti.PDF

Full article: In vitro evaluations for pharmacokinetic drug-drug interactions of a novel serotonin-dopamine activity modulator, brexpiprazole

REXULTI® (brexpiprazole), MDD

For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti Full Prescribing Information, Dosage & Side Effects

Brexpiprazole: A Newly Approved Atypical Antipsychotic Agent

PDF) Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review

Brexpiprazole - Mechanism of Action and Clinical Application

Recomendado para você